한글목차

C 반응성 단백질 검사 동향 및 예측

세계 C 반응성 단백질 검사 시장은 2024년부터 2030년까지 2.8%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 약 61억 달러 규모에 이를 것으로 예측됩니다. 이 시장의 주요 촉진요인은 심혈관 질환의 빈도 증가, C 반응성 단백질(CRP) 검사를 위한 최첨단 검사법 개발을 위한 정부 프로그램의 확대, 심혈관 질환, 류마티스 관절염, 염증성 질환과 같은 만성 질환의 비율 증가입니다. C 반응성 단백질 검사 시장의 미래는 클리닉, 병원, 검사실, 요양병원, 요양시설, 가정 시장 등에서의 기회로 인해 유망한 시장으로 평가됩니다.

C-반응성 단백질 검사 시장 인사이트

Lucintel은 심혈관 질환의 빈도가 증가함에 따라 심혈관 질환이 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

북미는 심혈관 질환 발병률 증가, 정기적인 제품 출시 흐름, 기존 업계 경쟁사의 존재로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 C 반응성 단백질 검사 시장은 2030년까지 약 61억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 전망은?

A2. 세계 C 반응성 단백질 검사 시장은 2024년부터 2030년까지 연평균 복합 성장률(CAGR) 2.8%를 나타낼 전망입니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A3. 이 시장의 주요 촉진요인은 심혈관 질환의 빈도 증가, 현장 진료 검진 도입 및 C 반응성 단백질(CRP) 검사의 최첨단 검사법 개발을 위한 정부 프로그램의 확대, 심혈관 질환, 류마티스 관절염, 염증성 질환과 같은 만성 질환의 유병률 증가입니다.

Q4. 시장의 주요 부문은?

A4. 세계 C 반응성 단백질 검사 시장의 미래는 클리닉, 병원, 검사실, 요양병원, 요양병원 및 가정 시장에서 유망합니다.

Q5. 시장의 주요 기업은?

A5. 주요 C 반응성 단백질 검사 기업은 다음과 같습니다.

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

Q6. 향후 가장 큰 시장 부문은?

A6.Lucintel은 심혈관 질환의 빈도가 증가함에 따라 예측 기간 동안 심혈관 질환이 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q7. 향후 5년간 가장 큰 시장으로 성장할 것으로 예상되는 지역은?

A7. 북미는 심혈관 질환 발병률 증가, 정기적인 제품 출시 흐름, 기존 업계 경쟁사의 존재로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 C 반응성 단백질 검사 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 C 반응성 단백질 검사 시장 동향(2018-2023년)과 예측(2024-2030년)
• 측정법별 세계의 C 반응성 단백질 검사 시장
  • 면역 비탁 측정법
  • ELISA
  • 화학 발광 면역측정
  • 기타
• 탐지 범위별 세계의 C 반응성 단백질 검사 시장
  • hsCRP(고감도 CRP)
  • 기존 CRP
  • cCRP(CardioPhase)
• 질환별 세계의 C 반응성 단백질 검사 시장
  • 심혈관 질환
  • 암
  • 류마티스 관절염
  • 염증성 장질환
  • 자궁내막증
  • 낭창
  • 기타
• 최종 용도별 세계의 C 반응성 단백질 검사 시장
  • 진료소
  • 병원
  • 연구실
  • 생활 지원 의료시설
  • 재택
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2023년)

• 지역별 세계의 C 반응성 단백질 검사 시장
• 북미의 C 반응성 단백질 검사 시장
• 유럽의 C 반응성 단백질 검사 시장
• 아시아태평양의 C 반응성 단백질 검사 시장
• 기타 지역의 C 반응성 단백질 검사 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 어세이 유형별 세계의 C 반응성 단백질 검사 시장 성장 기회
  • 탐지 범위별 세계의 C 반응성 단백질 검사 시장 성장 기회
  • 질환별 세계의 C 반응성 단백질 검사 시장 성장 기회
  • 최종 용도별 세계의 C 반응성 단백질 검사 시장 성장 기회
  • 지역별 세계의 C 반응성 단백질 검사 시장 성장 기회
• 세계 C 반응성 단백질 검사 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 C 반응성 단백질 검사 시장 능력 확대
  • 세계 C 반응성 단백질 검사 시장에서의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업 개요

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

영문목차

C-Reactive Protein Testing Trends and Forecast

The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets. The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

A more than 150-page report is developed to help in your business decisions.

C-Reactive Protein Testing by Segment

The study includes a forecast for the global C-reactive protein testing by assay type, detection range, disease, end use, and region.

C-Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

• Immunoturbidimetric Assay
• ELISA
• Chemiluminescence Immunoassay
• Others

C-Reactive Protein Testing Market by Detection Range [Shipment Analysis by Value from 2018 to 2030]:

• hs-CRP
• Conventional CRP
• cCRP

C-Reactive Protein Testing Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-Reactive Protein Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Laboratories
• Assisted Living Healthcare Facilities
• Home
• Others

C-Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of C-Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C-reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C-reactive protein testing companies profiled in this report include-

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

C-Reactive Protein Testing Market Insights

Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Features of the Global C-Reactive Protein Testing Market

Market Size Estimates: C-reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C-reactive protein testing market size by various segments, such as by assay type, detection range, disease, end use, and region in terms of value ($B).

Regional Analysis: C-reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay type, detection range, disease, end use, and regions for the C-reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C-reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C-reactive protein testing market size?

Answer: The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030.

Q2. What is the growth forecast for C-reactive protein testing market?

Answer: The global C-reactive protein testing market is expected to grow with a CAGR of 2.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C-reactive protein testing market?

Answer: The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

Q4. What are the major segments for C-reactive protein testing market?

Answer: The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets.

Q5. Who are the key C-reactive protein testing market companies?

Answer: Some of the key C-reactive protein testing companies are as follows.

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

Q6. Which C-reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

Q7. In C-reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the C-reactive protein testing market by assay type (immunoturbidimetric assay, elisa, chemiluminescence immunoassay, and others), detection range (hs-CRP, conventional CRP, and cCRP), disease (cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others), end use (clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C-Reactive Protein Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global C-Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global C-Reactive Protein Testing Market by Assay Type
  • 3.3.1: Immunoturbidimetric Assay
  • 3.3.2: ELISA
  • 3.3.3: Chemiluminescence Immunoassay
  • 3.3.4: Others
• 3.4: Global C-Reactive Protein Testing Market by Detection Range
  • 3.4.1: hs-CRP
  • 3.4.2: Conventional CRP
  • 3.4.3: cCRP
• 3.5: Global C-Reactive Protein Testing Market by Disease
  • 3.5.1: Cardiovascular Diseases
  • 3.5.2: Cancer
  • 3.5.3: Rheumatoid Arthritis
  • 3.5.4: Inflammatory Bowel Disease
  • 3.5.5: Endometriosis
  • 3.5.6: Lupus
  • 3.5.7: Others
• 3.6: Global C-Reactive Protein Testing Market by End Use
  • 3.6.1: Clinics
  • 3.6.2: Hospitals
  • 3.6.3: Laboratories
  • 3.6.4: Assisted Living Healthcare Facilities
  • 3.6.5: Home
  • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global C-Reactive Protein Testing Market by Region
• 4.2: North American C-Reactive Protein Testing Market
  • 4.2.1: North American C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.2.2: North American C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.3: European C-Reactive Protein Testing Market
  • 4.3.1: European C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.3.2: European C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.4: APAC C-Reactive Protein Testing Market
  • 4.4.1: APAC C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.4.2: APAC C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.5: ROW C-Reactive Protein Testing Market
  • 4.5.1: ROW C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.5.2: ROW C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global C-Reactive Protein Testing Market by Assay Type
  • 6.1.2: Growth Opportunities for the Global C-Reactive Protein Testing Market by Detection Range
  • 6.1.3: Growth Opportunities for the Global C-Reactive Protein Testing Market by Disease
  • 6.1.4: Growth Opportunities for the Global C-Reactive Protein Testing Market by End Use
  • 6.1.5: Growth Opportunities for the Global C-Reactive Protein Testing Market by Region
• 6.2: Emerging Trends in the Global C-Reactive Protein Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global C-Reactive Protein Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C-Reactive Protein Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: F. Hoffmann-La Roche
• 7.3: Danaher
• 7.4: Quest Diagnostics
• 7.5: Siemens Healthineers
• 7.6: Abbott
• 7.7: Merck
• 7.8: Zoetis
• 7.9: Ortho Clinical Diagnostics
• 7.10: Getein Biotech